Comparative assessment of antibacterial drugs used at the hos-pital level before and during COVID-19, according to the WHO AWaRe classification

Author:

Balapasheva Aigerim1,Ziganshina Liliya2,Mussina Aigul1,Smagulova Gaziza1,Kulnazarova Mariya3,Balymbetova Lazzat1

Affiliation:

1. West Kazakhstan Marat Ospanov State Medical University

2. Russian Medical Academy of Continuous Professional Education

3. Aktobe medical center

Abstract

Abstract

Background This study presents a comprehensive analysis of antibiotic consumption in a dispensary hospital in Aktobe, Kazakhstan, from 2019 to 2021, utilizing the World Health Organization's (WHO) "Access, Watch, and Reserve" (AWaRe) classification. Objective The primary objective of this study was to assess the patterns of antibiotic use in the hospital and to determine the extent to which the AWaRe classification could be effectively implemented in Kazakhstan to guide optimal antibiotic use and establish performance targets. Methods The study analyzed data on the consumption of systemic antibacterial drugs in the dispensary hospital from 2019 to 2021. The usage of antibiotics was classified according to the WHO's AWaRe classification, which categorizes antibiotics into three groups: "Access," "Watch," and "Reserve." Results The study revealed a concerning trend in the irrational consumption of systemic antibiotics. There was a notable decrease in the use of "Access" antibiotics from 39.13% in 2019 to 22% in 2021, which is contrary to WHO recommendations. Conversely, the use of "Watch" antibiotics increased, particularly during the COVID-19 pandemic. The most commonly used antibiotics were cephalosporins, fluoroquinolones, and carbapenems. Conclusion The findings underscore the urgent need for implementing the AWaRe classification database in Kazakhstan to guide optimal antibiotic use, set performance targets, and establish a working group to monitor and control the prescription and use of antibacterial drugs. This study contributes to the global understanding of antibiotic consumption patterns and the challenges faced in adhering to international guidelines, particularly in the context of a pandemic.

Publisher

Springer Science and Business Media LLC

Reference26 articles.

1. 7th meeting report of WHO advisory group on integrated surveillance of antimicrobial resistance (AGISAR). Geneva: World Health Organization. 2018. https://apps.who.int/iris/bitstream/handle/10665/272714/WHO-NMH-FOS-FZD-18.1- eng.pdf

2. The State of the World's Antibiotics. 2021. A Global Analysis of Antimicrobial Resistance and Its Drivers. The Center for Disease Dynamics, Economics & Policy (CDDEP), Inc. 2021. https://www.lshtm.ac.uk/research/centres/amr/news/227421/state-worlds-antibiotics2021

3. Improving the use of medicines in healthcare organizations to solve the problem of irrational use of medicines in the Republic of Kazakhstan;Zhussupova G;J Health Dev,2020

4. Bacterial Co-Infections and Antimicrobial Resistance in Patients Hospitalized with Suspected or Confirmed COVID-19 Pneumonia in Kazakhstan;Lavrinenko A;Pathogens,2023

5. Haileyesus G. (2020). Tackling antimicrobial resistance in the COVID-19 pandemic. Bulletin of the World Health Organization. 98, 442-442A. http://dx.doi.org/10.2471/BLT.20.268573

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3